Showing 35,221 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Human rights

Educating police on harm reduction can help to prevent HIV and fatal overdoses

News
31 July 2022
The search for a cure

Smart new single-cell assay shines a light on the HIV reservoir

News
31 July 2022
PrEP programmes & uptake

PrEP inequities have worsened in the US over the last decade, both racially and regionally

News
30 July 2022
HIV treatment for children & young people

Six-country study shows dolutegravir-based treatment is highly effective in children and adolescents

News
30 July 2022
Undetectable viral load & treatment as prevention

Gaps in U=U awareness globally: healthcare providers need to do more to get the message out

News
30 July 2022
Mpox

Spain reports first monkeypox-related death in Europe

Editor's pick
Reuters
30 July 2022
Exposure to HIV through medical procedures

UK: Infected blood victims set for £400m in compensation

Editor's pick
BBC News
29 July 2022
Weight gain & lipodystrophy

Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains

News
29 July 2022
PrEP policies & guidelines

WHO recommends long-acting cabotegravir for HIV prevention

Editor's pick
World Health Organization
29 July 2022
Hepatitis C transmission & prevention

Widespread PrEP use is not leading to more hepatitis C transmission among gay and bisexual men

News
29 July 2022
HIV treatment

Mozambique: Half a Million HIV-Positive People Abandon Anti-Retroviral Treatment

Editor's pick
AllAfrica
29 July 2022
Harm reduction

In Europe’s drug death capital, politicians plead for new powers to stem the tide

Editor's pick
POLITICO
29 July 2022
Government, leadership & policy

HIV campaign “U Equals U” has been adopted by entire US government

Editor's pick
My Fabulous Disease
29 July 2022
Ethnic & cultural minorities

Nothing about us, without us: Indigenous peoples lead from the front to #endAIDS

Editor's pick
The Nation
29 July 2022
Generic medicines

ViiV Healthcare to allow 90 countries to access generic versions of HIV prevention shot

News
28 July 2022
Mpox

WHO chief advises reducing sex partners to avoid monkeypox

Editor's pick
Associated Press
28 July 2022
Human rights

​Unlawful policing: A crisis crippling the HIV response

Editor's pick
Frontline AIDS
28 July 2022
Injectable & long-acting PrEP

ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine

Editor's pick
Medicines Patent Pool
28 July 2022
Injectable & long-acting PrEP

UNAIDS welcomes ViiV’s agreement to enable generic production of long acting PrEP to 90 countries

Editor's pick
UNAIDS
28 July 2022
Taking an HIV test

LeaSuwanna Griffith on HIV testing – Positive Champions Video

July 2022
HIV & criminal law

​Unlawful policing: A crisis crippling the HIV response

Editor's pick
Frontline AIDS
28 July 2022
Conference announcements & declarations

IAS President ‘very upset’ over AIDS 2022 visa denials

Editor's pick
Devex
28 July 2022
Access to healthcare

Obamacare back in court as Texans challenge coverage for STDs and HIV care

Editor's pick
Politico
28 July 2022
New & experimental HIV treatments

Gilead Sciences Statement on FDA Acceptance of New Drug Application for Investigational Lenacapavir

Editor's pick
Gilead Sciences press release
28 July 2022